Cargando…

Ethyl Pyruvate Reduces Systemic Leukocyte Activation via Caspase-1 and NF-κB After Blunt Chest Trauma and Haemorrhagic Shock

Background: Blunt chest (thoracic) trauma (TxT) and haemorrhagic shock with subsequent resuscitation (H/R) induce strong systemic and local inflammatory response, which is closely associated with apoptotic cell loss and subsequently impaired organ function. The underlying mechanisms are not complete...

Descripción completa

Detalles Bibliográficos
Autores principales: Dieteren, Scott, Franz, Niklas, Köhler, Kernt, Nowak, Aleksander, Ehnert, Sabrina, Surov, Alexey, Krüger, Marcus, Marzi, Ingo, Wagner, Nils, Relja, Borna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562791/
https://www.ncbi.nlm.nih.gov/pubmed/33117829
http://dx.doi.org/10.3389/fmed.2020.562904
_version_ 1783595348491501568
author Dieteren, Scott
Franz, Niklas
Köhler, Kernt
Nowak, Aleksander
Ehnert, Sabrina
Surov, Alexey
Krüger, Marcus
Marzi, Ingo
Wagner, Nils
Relja, Borna
author_facet Dieteren, Scott
Franz, Niklas
Köhler, Kernt
Nowak, Aleksander
Ehnert, Sabrina
Surov, Alexey
Krüger, Marcus
Marzi, Ingo
Wagner, Nils
Relja, Borna
author_sort Dieteren, Scott
collection PubMed
description Background: Blunt chest (thoracic) trauma (TxT) and haemorrhagic shock with subsequent resuscitation (H/R) induce strong systemic and local inflammatory response, which is closely associated with apoptotic cell loss and subsequently impaired organ function. The underlying mechanisms are not completely understood, therefore, the treatment of patients suffering from TxT+H/R is challenging. In our recent studies, we have demonstrated local anti-inflammatory effects of ethyl pyruvate (EtP) in lung and liver after TxT+H/R. Here, the therapeutic potential of a reperfusion regime with EtP on the early post-traumatic systemic inflammatory response and apoptotic changes after TxT followed by H/R were investigated. Methods: Female Lewis rats underwent TxT followed by haemorrhagic shock (60 min). Resuscitation was performed with own blood transfusion and either lactated Ringers solution (LR) or LR supplemented with EtP (50 mg/kg). Sham group underwent the surgical procedures. After 2 h blood as well as lung and liver tissues were obtained for analyses. Systemic activation of neutrophils (expression of CD11b and CD62L), leukocyte phagocytosis, apoptosis (caspase-3/7 activation), pyroptosis (caspase-1 activation) and NF-κB p65 activity were assessed. p < 0.05 was considered significant. Results: TxT+H/R-induced systemic activation of neutrophils (increased CD11b and reduced CD62L expression) was significantly reduced by EtP. Trauma-induced delayed neutrophil apoptosis was further reduced by EtP reperfusion but remained unaltered in monocytes. Reperfusion with EtP significantly increased the phagocytizing capacity of granulocytes. Trauma-induced inflammasome activation, which was observed in monocytes and not in neutrophils, was significantly reduced by EtP in both cell entities. NF-κB p65 activation, which was increased in neutrophils and monocytes was significantly decreased in monocytes. Conclusion: TxT+H/R-induced systemic activation of both neutrophils and monocytes concomitant with increased systemic inflammation was reduced by a reperfusion with EtP and was associated with a down-regulation of NF-κB p65 activation.
format Online
Article
Text
id pubmed-7562791
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75627912020-10-27 Ethyl Pyruvate Reduces Systemic Leukocyte Activation via Caspase-1 and NF-κB After Blunt Chest Trauma and Haemorrhagic Shock Dieteren, Scott Franz, Niklas Köhler, Kernt Nowak, Aleksander Ehnert, Sabrina Surov, Alexey Krüger, Marcus Marzi, Ingo Wagner, Nils Relja, Borna Front Med (Lausanne) Medicine Background: Blunt chest (thoracic) trauma (TxT) and haemorrhagic shock with subsequent resuscitation (H/R) induce strong systemic and local inflammatory response, which is closely associated with apoptotic cell loss and subsequently impaired organ function. The underlying mechanisms are not completely understood, therefore, the treatment of patients suffering from TxT+H/R is challenging. In our recent studies, we have demonstrated local anti-inflammatory effects of ethyl pyruvate (EtP) in lung and liver after TxT+H/R. Here, the therapeutic potential of a reperfusion regime with EtP on the early post-traumatic systemic inflammatory response and apoptotic changes after TxT followed by H/R were investigated. Methods: Female Lewis rats underwent TxT followed by haemorrhagic shock (60 min). Resuscitation was performed with own blood transfusion and either lactated Ringers solution (LR) or LR supplemented with EtP (50 mg/kg). Sham group underwent the surgical procedures. After 2 h blood as well as lung and liver tissues were obtained for analyses. Systemic activation of neutrophils (expression of CD11b and CD62L), leukocyte phagocytosis, apoptosis (caspase-3/7 activation), pyroptosis (caspase-1 activation) and NF-κB p65 activity were assessed. p < 0.05 was considered significant. Results: TxT+H/R-induced systemic activation of neutrophils (increased CD11b and reduced CD62L expression) was significantly reduced by EtP. Trauma-induced delayed neutrophil apoptosis was further reduced by EtP reperfusion but remained unaltered in monocytes. Reperfusion with EtP significantly increased the phagocytizing capacity of granulocytes. Trauma-induced inflammasome activation, which was observed in monocytes and not in neutrophils, was significantly reduced by EtP in both cell entities. NF-κB p65 activation, which was increased in neutrophils and monocytes was significantly decreased in monocytes. Conclusion: TxT+H/R-induced systemic activation of both neutrophils and monocytes concomitant with increased systemic inflammation was reduced by a reperfusion with EtP and was associated with a down-regulation of NF-κB p65 activation. Frontiers Media S.A. 2020-10-02 /pmc/articles/PMC7562791/ /pubmed/33117829 http://dx.doi.org/10.3389/fmed.2020.562904 Text en Copyright © 2020 Dieteren, Franz, Köhler, Nowak, Ehnert, Surov, Krüger, Marzi, Wagner and Relja. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Dieteren, Scott
Franz, Niklas
Köhler, Kernt
Nowak, Aleksander
Ehnert, Sabrina
Surov, Alexey
Krüger, Marcus
Marzi, Ingo
Wagner, Nils
Relja, Borna
Ethyl Pyruvate Reduces Systemic Leukocyte Activation via Caspase-1 and NF-κB After Blunt Chest Trauma and Haemorrhagic Shock
title Ethyl Pyruvate Reduces Systemic Leukocyte Activation via Caspase-1 and NF-κB After Blunt Chest Trauma and Haemorrhagic Shock
title_full Ethyl Pyruvate Reduces Systemic Leukocyte Activation via Caspase-1 and NF-κB After Blunt Chest Trauma and Haemorrhagic Shock
title_fullStr Ethyl Pyruvate Reduces Systemic Leukocyte Activation via Caspase-1 and NF-κB After Blunt Chest Trauma and Haemorrhagic Shock
title_full_unstemmed Ethyl Pyruvate Reduces Systemic Leukocyte Activation via Caspase-1 and NF-κB After Blunt Chest Trauma and Haemorrhagic Shock
title_short Ethyl Pyruvate Reduces Systemic Leukocyte Activation via Caspase-1 and NF-κB After Blunt Chest Trauma and Haemorrhagic Shock
title_sort ethyl pyruvate reduces systemic leukocyte activation via caspase-1 and nf-κb after blunt chest trauma and haemorrhagic shock
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562791/
https://www.ncbi.nlm.nih.gov/pubmed/33117829
http://dx.doi.org/10.3389/fmed.2020.562904
work_keys_str_mv AT dieterenscott ethylpyruvatereducessystemicleukocyteactivationviacaspase1andnfkbafterbluntchesttraumaandhaemorrhagicshock
AT franzniklas ethylpyruvatereducessystemicleukocyteactivationviacaspase1andnfkbafterbluntchesttraumaandhaemorrhagicshock
AT kohlerkernt ethylpyruvatereducessystemicleukocyteactivationviacaspase1andnfkbafterbluntchesttraumaandhaemorrhagicshock
AT nowakaleksander ethylpyruvatereducessystemicleukocyteactivationviacaspase1andnfkbafterbluntchesttraumaandhaemorrhagicshock
AT ehnertsabrina ethylpyruvatereducessystemicleukocyteactivationviacaspase1andnfkbafterbluntchesttraumaandhaemorrhagicshock
AT surovalexey ethylpyruvatereducessystemicleukocyteactivationviacaspase1andnfkbafterbluntchesttraumaandhaemorrhagicshock
AT krugermarcus ethylpyruvatereducessystemicleukocyteactivationviacaspase1andnfkbafterbluntchesttraumaandhaemorrhagicshock
AT marziingo ethylpyruvatereducessystemicleukocyteactivationviacaspase1andnfkbafterbluntchesttraumaandhaemorrhagicshock
AT wagnernils ethylpyruvatereducessystemicleukocyteactivationviacaspase1andnfkbafterbluntchesttraumaandhaemorrhagicshock
AT reljaborna ethylpyruvatereducessystemicleukocyteactivationviacaspase1andnfkbafterbluntchesttraumaandhaemorrhagicshock